Spencer Pharmaceutical is a multi disciplinary company, which develops several patented drug platforms technologies for the treatment of Neurological diseases such as Alzheimer, Parkinson, and Multiple Scleroses as well as patented slow release drug delivery technology for the treatment of type-2 diabetes and arthritis
Fiscal Year End 12/31 OTC Market Tier Pink Sheets Limited
Profile Data SIC - Industry Classification 2834 - Pharmaceutical preparations Business Status Development Stage Company
Incorporated In: DE, USA Year of Inc. 1998 Employees 9 a/o Dec 31, 2009
Company Officers Max Arella Dir. Ian Morrice EVP Jean Francis Amyot VP, Bus. Affairs
Company Notes •Formerly=EmergenSys Corp. until 10-2009 •Formerly=Medical Licensing International Corp. until 12-03 •Formerly=MoliChem Medicines, Inc. until 7-03 •Formerly=Cortez Development Ltd. until 3-01 SPPH Security Details Share Structure Market Value1 $74,945,094 a/o Dec 10, 2010 Shares Outstanding 258,431,359 a/o Jun 30, 2010 Float 45,429,759 a/o Feb 25, 2010
Authorized Shares 480,000,000 a/o Jun 30, 2010 Par Value 0.0010
Shareholders Shareholders of Record 109 a/o Feb 25, 2010 Beneficial Shareholders N/A
Corporate Actions Ex. Date Record Date Pay Date
Security Notes •Capital Change=shs increased by 6.959314 for 1 split Ex-date=01/26/2001. Rec date=01/11/2001. Pay date=01/25/2001.
Non US Stock Exchange Listing -
Short Selling Data Short Interest 40,264 (100%) Nov 30, 2010 Significant Failures to Deliver No
Transfer Agent(s) Interwest Transfer Co., Inc. Service Providers Auditor/Accountant
Laposta & Associates 8530 Champ D'Eau PQ, H1P 1Y3 United States
Legal Counsel
Mitch Segal, Attorney at Law 626 RXR Plaza NY, 11556 United States
Investor Relations Firm
Hilbroy Advisory Inc. 1400 Begin QC, H4R1X1 Canada
Market Data 
Markets 
AI
